Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MPO | P05164 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1934015 | 0.88 | — | — | |
| SCHEMBL939073 | 0.87 | MEN1 (0.30) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL3159705 | 0.85 | GAA (0.30) | GAA | |
| SCHEMBL3383842 | 0.85 | — | — | |
| SCHEMBL3380689 | 0.85 | MPO (0.43) | GAAMPO | |
| SCHEMBL3741118 | 0.84 | CYP2C9 (0.33) | GAAMPOMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL1935019 | 0.84 | GAA (0.32) | GAAMPOMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL19510500 | 0.82 | GAA (0.33) | GAAMPO | |
| SCHEMBL3383844 | 0.81 | CYP1A2 (0.34) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL3383487 | 0.81 | LMNA (0.32) | GAAMPOKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250361225-A1 | A PROCESS FOR PREPARATION OF 3-[5-(DIFLUOROMETHOXY)-1- METHYL-3-(TRIFLUOROMETHYL)PYRAZOL-4- YLMETHYLSULFONYL]-4,5-DIHYDRO-5,5-DIMETHYL-1,2-OXAZOLE AND ITS INTERMEDIATES | UPL LTD (IN) | 2025-11-27 | — | — | US | disclosed |
| US-20240279212-A1 | NOVEL INTERMEDIATE FOR PREPARATION OF PYROXASULFONE | UPL LIMITED (IN) | 2024-08-22 | — | — | US | disclosed |
| WO-2023194957-A1 | A PROCESS FOR PREPARATION OF 3-[5-(DIFLUOROMETHOXY)-1- METHYL-3-(TRIFLUOROMETHYL)PYRAZOL-4- YLMETHYLSULFONYL]-4,5-DIHYDRO-5,5-DIMETHYL-1,2-OXAZOLE AND ITS INTERMEDIATES | UPL LIMITED (IN) | 2023-10-12 | — | — | WO | disclosed |
| WO-2022249203-A1 | NOVEL INTERMEDIATE FOR PREPARATION OF PYROXASULFONE | UPL LIMITED (IN) | 2022-12-01 | — | — | WO | disclosed |
| CN-112969697-A | Process for producing herbicide and intermediate thereof | 组合化学工业株式会社 | 2021-06-15 | — | — | CN | disclosed |
| EP-1364946-B1 | ISOXAZOLINE DERIVATIVE AND HERBICIDE COMPRISING THE SAME AS ACTIVE INGREDIENT | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2010-11-24 | — | — | EP | disclosed |
| US-7833939-B2 | Herbicide compositions | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-11-16 | — | — | US | disclosed |
| EP-2186410-A1 | Isoxazoline derivative and herbicide comprising the same as active ingredient | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-05-19 | — | — | EP | disclosed |
| US-7238689-B2 | Isoxazoline derivative and herbicide comprising the same as active ingredient | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-07-03 | — | — | US | disclosed |
| US-20050256004-A1 | Herbicide compositions | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2005-11-17 | — | — | US | disclosed |
| US-20040110749-A1 | Isoxazoline derivative and herbicide comprising the same as active ingredient | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-06-10 | — | — | US | disclosed |
| EP-1364946-A1 | ISOXAZOLINE DERIVATIVE AND HERBICIDE COMPRISING THE SAME AS ACTIVE INGREDIENT | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2003-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361225-A1 | A PROCESS FOR PREPARATION OF 3-[5-(DIFLUOROMETHOXY)-1- METHYL-3-(TRIFLUOROMETHYL)PYRAZOL-4- YLMETHYLSULFONYL]-4,5-DIHYDRO-5,5-DIMETHYL-1,2-OXAZOLE AND ITS INTERMEDIATES | DHPS, DHODH, FIS1 | GAA 3825/4885MPO 2447/4885MEN1 1388/4885 |
| US-20050256004-A1 | Herbicide compositions | DDT, CYP4X1, GLRX3 | GAA 1861/4885MPO 2230/4885MEN1 4458/4885 |
| US-20240279212-A1 | NOVEL INTERMEDIATE FOR PREPARATION OF PYROXASULFONE | CYP11B1, CYP11B2, DHPS | GAA 3244/4885MPO 332/4885MEN1 396/4885 |
| US-20040110749-A1 | Isoxazoline derivative and herbicide comprising the same as active ingredient | CYP4X1, PRDX5, CYP3A7 | GAA 2474/4885MPO 983/4885MEN1 4827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.